Market cap
₹2 Cr
Recently Viewed
Clear AllNSE: SHARONBIO | BSE: 532908
₹3.30
₹-0.15
(-4.35%)
As on 28-Mar-2019IST
Market cap
₹2 Cr
Revenue (TTM)
₹197 Cr
P/E Ratio
0.1
P/B Ratio
-0.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹23 Cr
ROE
62.7 %
ROCE
25.2 %
Industry P/E
--
EV/EBITDA
27
Debt to Equity
2.5
Book Value
₹19532.4
EPS
₹9271.6
Face value
2
Shares outstanding
5,755,625
CFO
₹88.10 Cr
EBITDA
₹-352.70 Cr
Net Profit
₹-731.77 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sharon Bio-Medicine
| -34.7 | -4.3 | -34.7 | -42.1 | -34.4 | -39.9 | -- |
|
BSE Sensex*
| -9.2 | 4.5 | -6.1 | -2.9 | 8.2 | 9.5 | 11.4 |
|
BSE Healthcare#
| 2.6 | 5.0 | 8.0 | 6.4 | 25.0 | 13.8 | 11.1 |
|
Company
|
2018
|
2017
|
2016
|
2015
|
2014
|
|---|---|---|---|---|---|
|
Sharon Bio-Medicine
| -29.4 | -21.0 | -66.8 | -25.2 | -14.2 |
|
BSE Sensex
| 5.9 | 27.9 | 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| -5.9 | 0.5 | -12.9 | 15.1 | 47.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sharon Bio-Medicine
|
3.3 | 1.9 | 197.5 | 23.2 | 7.5 | 62.7 | 0.1 | -0.1 |
| 2,467.8 | 20,207.0 | 1,215.1 | 284.8 | 28.7 | 21.1 | 70.4 | 13.3 | |
| 705.2 | 17,470.9 | 5,092.5 | 545.5 | 15.9 | 14.1 | 32 | 3.9 | |
| 942.5 | 14,987.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 34.6 | 2.3 | |
| 1,094.1 | 19,596.4 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.6 | 2.2 | |
| 1,763.0 | 20,205.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1005.2 | 3.5 | |
| 164.5 | 21,839.6 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.8 | |
| 954.7 | 15,744.8 | 1,284.3 | 134.4 | -- | 30.7 | 117.2 | 12.9 | |
| 440.3 | 17,729.3 | 3,720.2 | 352.1 | 13.7 | 8.2 | 50.4 | 3.7 | |
| 1,417.3 | 23,027.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 1046.7 | 5.0 |
2 min read•By Vikas Vardhan
Manufacture of allopathic pharmaceutical preparations
Incorporated
1989
Chairman
--
Managing Director
--
Headquarters
Raigad, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Sharon Bio-Medicine Ltd is ₹3.30 (NSE) and ₹3.21 (BSE) as of 28-Mar-2019 IST. Sharon Bio-Medicine Ltd has given a return of -34.42% in the last 3 years.
The P/E ratio of Sharon Bio-Medicine Ltd is 0.10 times as on 28-Mar-2019.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2017
|
0.00
|
-0.17
|
The 52-week high and low of Sharon Bio-Medicine Ltd are Rs -- and Rs -- as of 29-Apr-2026.
Sharon Bio-Medicine Ltd has a market capitalisation of ₹ 2 Cr as on 28-Mar-2019. As per SEBI classification, it is a company.
Before investing in Sharon Bio-Medicine Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.